1. Long-term proton pump inhibitor therapy and osteoporosis. Is there a real danger?
   József Maléth et al, 2013, Orvosi Hetilap CrossRef
2. Proton Pump Inhibitors and Bone Health
   Scott C. Wagner, 2018, JBJS Reviews CrossRef
3. Proton pump inhibitors’ use and risk of hip fracture: a systematic review and meta-analysis
   Salman Hussain et al, 2018, Rheumatology International CrossRef
4. Proton‐Pump Inhibitors
   Marta Tavares et al, 2021, Journal of Pediatric Gastroenterology and Nutrition CrossRef
5. Proton Pump Inhibitor Use, H2-Receptor Antagonist Use, and Risk of Incident Clinical Vertebral Fracture in Women
   Julie M. Paik et al, 2018, Calcified Tissue International CrossRef
6. Proton pump inhibitors and fracture risk. The HUNT study, Norway
   M. Hoff et al, 2020, Osteoporosis International CrossRef
7. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies
   T.N. Poly et al, 2019, Osteoporosis International CrossRef
8. Treatment effect of Bushen Huayu extract on postmenopausal osteoporosis in vivo
   LU OUYANG et al, 2014, Experimental and Therapeutic Medicine CrossRef
9. Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo
   Yu-Xi Li et al, 2020, Stem Cells International CrossRef
10. Skeletal effects of a gastrin receptor antagonist in H+/K+ATPase beta subunit KO mice
    Kristin M Aasarød et al, 2016, Journal of Endocrinology CrossRef
11. Evaluation of the Impact of Different Pain Medication and Proton Pump Inhibitors on the Osteogenic Differentiation Potential of hMSCs Using 99mTc-HDP Labelling
    Tobias Grossner et al, 2021, Life CrossRef
12. A Proton Pump Inhibitor's Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized Study
    Yunju Jo et al, 2015, Gut and Liver CrossRef
13. Adverse skeletal effects of drugs – beyond Glucocorticoids
    Susannah O'Sullivan et al, 2015, Clinical Endocrinology CrossRef
14. The impact of proton pump inhibitors on bone regeneration and implant osseointegration
    Alexandru Mester et al, 2019, Drug Metabolism Reviews CrossRef
15. A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long‐Term Safety
    E Dubcenco et al, 2017, Clinical and Translational Science CrossRef
16. Biomechanical and biochemical evaluation of the effect of systemic application of omeprazole on the osseointegration of titanium implants
    Samet Tekin et al, 2021, International Journal of Implant Dentistry CrossRef
17. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study
    D. E. Freedberg et al, 2015, Osteoporosis International CrossRef